Jade Biosciences appoints Dr. Mark Eisner to Board of Directors
Jade Biosciences, Inc. (JBIO) announced the appointment of veteran biopharmaceutical executive Dr. Mark Eisner to its board of directors. This leadership addition is expected to bolster the company's efforts in advancing its antibody-based autoimmune therapies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day